HIP DYSPLASIA, CONGENITAL
Clinical trials for HIP DYSPLASIA, CONGENITAL explained in plain language.
Never miss a new study
Get alerted when new HIP DYSPLASIA, CONGENITAL trials appear
Sign up with your email to follow new studies for HIP DYSPLASIA, CONGENITAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could skipping the brace be just as good for baby hips?
Disease control Recruiting nowThis study looks at whether careful monitoring is as effective as bracing for babies under 3 months with mild hip dysplasia. Bracing can disrupt bonding and daily life, so avoiding unnecessary treatment could help families. The trial will involve 514 babies across 7 countries to …
Matched conditions: HIP DYSPLASIA, CONGENITAL
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated May 17, 2026 16:08 UTC
-
New hip resurfacing device tracked for 10 years
Disease control Recruiting nowThis study follows 150 people aged 18 to 65 who receive a ROMAX hip resurfacing implant to treat hip arthritis or congenital hip dysplasia. Researchers will monitor how long the implant lasts and measure hip function and patient satisfaction over 10 years. The goal is to confirm …
Matched conditions: HIP DYSPLASIA, CONGENITAL
Sponsor: Medacta International SA • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC